{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:47:08Z","timestamp":1792784828042,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health (NIH)","doi-asserted-by":"crossref","award":["P01AI058113"],"award-info":[{"award-number":["P01AI058113"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Institute of Allergy and Infectious Diseases, NIH, Department of Health and Human Services, USA","id":[{"id":"https:\/\/ror.org\/05p26gw61","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.antiviral.2013.03.021","type":"journal-article","created":{"date-parts":[[2013,4,9]],"date-time":"2013-04-09T23:15:09Z","timestamp":1365549309000},"page":"476-483","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":148,"title":["Broadly neutralizing antibodies against influenza viruses"],"prefix":"10.1016","volume":"98","author":[{"given":"Nick S.","family":"Laursen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian A.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2013.03.021_b0005","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4161\/hv.8.1.17623","article-title":"The rationale for quadrivalent influenza vaccines","volume":"8","author":"Ambrose","year":"2012","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.antiviral.2013.03.021_b0010","doi-asserted-by":"crossref","first-page":"13701","DOI":"10.1073\/pnas.1007465107","article-title":"Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge","volume":"107","author":"Bommakanti","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.antiviral.2013.03.021_b0020","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/371037a0","article-title":"Structure of influenza haemagglutinin at the pH of membrane fusion","volume":"371","author":"Bullough","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2013.03.021_b0025","doi-asserted-by":"crossref","first-page":"6852","DOI":"10.1016\/j.vaccine.2007.07.027","article-title":"Influenza vaccine: the challenge of antigenic drift","volume":"25","author":"Carrat","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2013.03.021_b0030","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0092-8674(82)90135-0","article-title":"The antigenic structure of the influenza virus A\/PR\/8\/34 hemagglutinin (H1 subtype)","volume":"31","author":"Caton","year":"1982","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2013.03.021_b0035","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0140-6736(97)11212-0","article-title":"Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus","volume":"351","author":"Claas","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2013.03.021_b0040","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.1205669","article-title":"A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins","volume":"333","author":"Corti","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2013.03.021_b0045","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1056\/NEJMoa054512","article-title":"Oseltamivir resistance during treatment of influenza A (H5N1) infection","volume":"353","author":"de Jong","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2013.03.021_b0050","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1126\/science.1222908","article-title":"Highly conserved protective epitopes on influenza B viruses","volume":"337","author":"Dreyfus","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2013.03.021_b0265","doi-asserted-by":"crossref","unstructured":"Dreyfus C.,Ekiert D.C., Wilson I.A. Structure of a classical broadly neutralizing stem antibody in complex with a pandemic H2 hemagglutinin. J Virol. 2013. [Epub ahead of print].","DOI":"10.1128\/JVI.02975-12"},{"key":"10.1016\/j.antiviral.2013.03.021_b0055","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1126\/science.1171491","article-title":"Antibody recognition of a highly conserved influenza virus epitope","volume":"324","author":"Ekiert","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2013.03.021_b0060","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1126\/science.1204839","article-title":"A highly conserved neutralizing epitope on group 2 influenza A viruses","volume":"333","author":"Ekiert","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2013.03.021_b0065","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nature11414","article-title":"Cross-neutralization of influenza A viruses mediated by a single antibody loop","volume":"489","author":"Ekiert","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2013.03.021_b0070","first-page":"1","article-title":"Prevention and control of influenza with vaccines: recommendations of the advisory committee on immunization practices (ACIP), 2010","volume":"59","author":"Fiore","year":"2010","journal-title":"MMWR Recomm. Rep."},{"key":"10.1016\/j.antiviral.2013.03.021_b0075","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1202617","article-title":"Computational design of proteins targeting the conserved stem region of influenza hemagglutinin","volume":"332","author":"Fleishman","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2013.03.021_b0080","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0140-6736(99)11433-8","article-title":"Influenza virus neuraminidase inhibitors","volume":"355","author":"Gubareva","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2013.03.021_b0085","doi-asserted-by":"crossref","first-page":"19123","DOI":"10.1073\/pnas.0607614103","article-title":"Influenza virus pleiomorphy characterized by cryoelectron tomography","volume":"103","author":"Harris","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.antiviral.2013.03.021_b0090","doi-asserted-by":"crossref","first-page":"11756","DOI":"10.1128\/JVI.01460-06","article-title":"Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines","volume":"80","author":"He","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.03.021_b0095","doi-asserted-by":"crossref","first-page":"10366","DOI":"10.1128\/JVI.01200-09","article-title":"Zanamivir-resistant influenza viruses with a novel neuraminidase mutation","volume":"83","author":"Hurt","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.03.021_b0100","doi-asserted-by":"crossref","first-page":"e1000990","DOI":"10.1371\/journal.ppat.1000990","article-title":"Protection from the 2009 H1N1 pandemic influenza by an antibody from combinatorial survivor-based libraries","volume":"6","author":"Kashyap","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2013.03.021_b0110","doi-asserted-by":"crossref","first-page":"6334","DOI":"10.1128\/JVI.07158-11","article-title":"Human monoclonal antibodies to pandemic 1957 H2N2 and pandemic 1968 H3N2 influenza viruses","volume":"86","author":"Krause","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.03.021_b0115","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1056\/NEJMra1002842","article-title":"Influenza vaccines for the future","volume":"363","author":"Lambert","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2013.03.021_b0120","doi-asserted-by":"crossref","first-page":"17040","DOI":"10.1073\/pnas.1212371109","article-title":"Heterosubtypic antibody recognition of the influenza virus hemagglutinin receptor binding site enhanced by avidity","volume":"109","author":"Lee","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.antiviral.2013.03.021_b0125","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nature11371","article-title":"Structural and genetic basis for development of broadly neutralizing influenza antibodies","volume":"489","author":"Lingwood","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2013.03.021_b0130","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1128\/AAC.01339-05","article-title":"Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3years of their use","volume":"50","author":"Monto","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2013.03.021_b0135","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1128\/JVI.80.7.3675-3678.2006","article-title":"Comparison of the mutation rates of human influenza A and B viruses","volume":"80","author":"Nobusawa","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.03.021_b0140","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1128\/JVI.67.5.2552-2558.1993","article-title":"A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains","volume":"67","author":"Okuno","year":"1993","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.03.021_b0145","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1126\/science.288.5468.1051","article-title":"Influenza B virus in seals","volume":"288","author":"Osterhaus","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2013.03.021_b0150","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1128\/JVI.67.6.3048-3060.1993","article-title":"Role of conserved glycosylation sites in maturation and transport of influenza A virus hemagglutinin","volume":"67","author":"Roberts","year":"1993","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.03.021_b0155","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0042-6822(90)90186-U","article-title":"Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983","volume":"175","author":"Rota","year":"1990","journal-title":"Virology"},{"issue":"Pt 7","key":"10.1016\/j.antiviral.2013.03.021_b0160","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1099\/0022-1317-77-7-1483","article-title":"The immunological activity of a deletion mutant of influenza virus haemagglutinin lacking the globular region","volume":"77","author":"Sagawa","year":"1996","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2013.03.021_b0165","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0166-3542(00)00111-X","article-title":"Antibodies for the prevention and treatment of viral diseases","volume":"47","author":"Sawyer","year":"2000","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.03.021_b0170","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00018-10","article-title":"Influenza virus vaccine based on the conserved hemagglutinin stalk domain","volume":"1","author":"Steel","year":"2010","journal-title":"MBio"},{"key":"10.1016\/j.antiviral.2013.03.021_b0175","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nsmb.1566","article-title":"Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses","volume":"16","author":"Sui","year":"2009","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.antiviral.2013.03.021_b0180","doi-asserted-by":"crossref","first-page":"6179","DOI":"10.1128\/JVI.00469-12","article-title":"A pan-H1 anti-hemagglutinin monoclonal antibody with potent broad-spectrum efficacy in vivo","volume":"86","author":"Tan","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.03.021_b0185","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1001\/jama.292.11.1333","article-title":"Influenza-associated hospitalizations in the United States","volume":"292","author":"Thompson","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.antiviral.2013.03.021_b0190","doi-asserted-by":"crossref","first-page":"e3942","DOI":"10.1371\/journal.pone.0003942","article-title":"Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells","volume":"3","author":"Throsby","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2013.03.021_b0195","doi-asserted-by":"crossref","first-page":"e1003067","DOI":"10.1371\/journal.ppat.1003067","article-title":"Influenza human monoclonal antibody 1F1 interacts with three major antigenic sites and residues mediating human receptor specificity in H1N1 viruses","volume":"8","author":"Tsibane","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2013.03.021_b0200","doi-asserted-by":"crossref","first-page":"18979","DOI":"10.1073\/pnas.1013387107","article-title":"Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes","volume":"107","author":"Wang","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.antiviral.2013.03.021_b0205","doi-asserted-by":"crossref","first-page":"e1000796","DOI":"10.1371\/journal.ppat.1000796","article-title":"Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins","volume":"6","author":"Wang","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2013.03.021_b0210","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1128\/MMBR.56.1.152-179.1992","article-title":"Evolution and ecology of influenza A viruses","volume":"56","author":"Webster","year":"1992","journal-title":"Microbiol. Rev."},{"key":"10.1016\/j.antiviral.2013.03.021_b0215","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1126\/science.1192517","article-title":"Induction of broadly neutralizing H1N1 influenza antibodies by vaccination","volume":"329","author":"Wei","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2013.03.021_b0220","doi-asserted-by":"crossref","first-page":"147ra114","DOI":"10.1126\/scitranslmed.3004273","article-title":"Elicitation of broadly neutralizing influenza antibodies in animals with previous influenza exposure","volume":"4","author":"Wei","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.antiviral.2013.03.021_b0225","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nbt.2214","article-title":"Optimization of affinity, specificity and function of designed influenza inhibitors using deep sequencing","volume":"30","author":"Whitehead","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.antiviral.2013.03.021_b0230","doi-asserted-by":"crossref","first-page":"14216","DOI":"10.1073\/pnas.1111497108","article-title":"Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin","volume":"108","author":"Whittle","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.antiviral.2013.03.021_b0235","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/289373a0","article-title":"Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation","volume":"289","author":"Wiley","year":"1981","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2013.03.021_b0240","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/289366a0","article-title":"Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3A resolution","volume":"289","author":"Wilson","year":"1981","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2013.03.021_b0270","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1126\/science.1186430","article-title":"Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus","volume":"328","author":"Xu","year":"2010","journal-title":"Science."},{"key":"10.1016\/j.antiviral.2013.03.021_b0245","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nsmb.2500","article-title":"A recurring motif for antibody recognition of the receptor-binding site of influenza hemagglutinin","volume":"20","author":"Xu","year":"2013","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.antiviral.2013.03.021_b0250","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/0042-6822(88)90238-3","article-title":"Influenza B virus evolution: co-circulating lineages and comparison of evolutionary pattern with those of influenza A and C viruses","volume":"163","author":"Yamashita","year":"1988","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2013.03.021_b0255","doi-asserted-by":"crossref","first-page":"e1000350","DOI":"10.1371\/journal.ppat.1000350","article-title":"Cross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses","volume":"5","author":"Yoshida","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2013.03.021_b0260","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/nature04817","article-title":"Distribution and three-dimensional structure of AIDS virus envelope spikes","volume":"441","author":"Zhu","year":"2006","journal-title":"Nature"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354213000843?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354213000843?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,25]],"date-time":"2020-07-25T00:57:04Z","timestamp":1595638624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354213000843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0166354213000843"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2013.03.021","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Broadly neutralizing antibodies against influenza viruses","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2013.03.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}